PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|August 2, 2021
- Pharmaceutical Technology, August 2021 Issue
- Volume 45
- Issue 8
Syringe Inspection Line
Author(s)Pharmaceutical Technology Editors
Syntegon's Syringe Inspection Line utilizes an AI vision system for the inspection of syringe flanges, stoppers, and cylinders.
Syntegon’s integrated syringe visual inspection line features a de-nester, a re-nester, and built-in artificial intelligence (AI) functionality for the inspection of syringe flanges, stoppers, and cylinders. The system, which can output up to 18,000 syringes per hour, is based on the company’s AIM5 series.
The AI vision system is designed to increase detection rates and decrease the number of false rejects for highly viscous parenteral solutions with air bubbles. Static Division technology is used to perform the visual particle inspection. A high-voltage leak detection module can be integrated for CCI testing.
Articles in this issue
about 5 years ago
Putting the Patient at the Heart of Dosage Form Designabout 5 years ago
A Digital Supply Chain Helps Ensure API Qualityabout 5 years ago
Serialization: Reducing Counterfeit Drugs and Increasing Salesabout 5 years ago
Designing Incubators for Cell Therapy Manufacturingabout 5 years ago
Implementing Data Integrity Compliance in a GLP Test Facilityabout 5 years ago
Developing the Best Formulation Partnershipabout 5 years ago
Working Towards Zero Emissionsabout 5 years ago
FDA Prioritizes Vaccine Review and Process ImprovementsRelated to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.